Skip to main content
All lobbying filings

RK STRATEGIES, INC.

Lobbying for ADIAL PHARMACEUTICALS, INC. · Pharmaceutical company

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $10,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 1
  • HR 7091
    Expanding Veterans’ Access to Emerging Treatments Act
 Lobbying activity 2
Health Issues

FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act National Defense Authorization Act, FY27

Defense

FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act National Defense Authorization Act, FY27

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem